Discussion
From Cancer Guidelines Wiki
Guidelines developed in partnership with
This resource has been developed, reviewed or revised more than five years ago. It may no longer reflect current evidence or best practice.
Published: 2015
National Health and Medical Research Council
Chapter 1 Risk
Discussion
Unresolved issues
The degree to which increased PSA testing of asymptomatic men with a family history of prostate cancer contributes to, or explains, their observed increased probability of being diagnosed with prostate cancer is unknown.
Future research priorities
The contribution of increased PSA testing of asymptomatic men with a family history to the observed increased probability of being diagnosed with prostate cancer needs to be quantified. This could be achieved through long-term prospective cohort studies of Australian men.